Skip to main content
Log in

ECCO2R in COPD exacerbation: response to comments by Del Sorbo et al.

  • Correspondence
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Del Sorbo SL, Fan E, Nava S, Ranieri VM (2016) ECCO2R in COPD exacerbation only for the right patients and with the right strategy. Intensive Care Med. doi:10.1007/s00134-016-4493-2

    Google Scholar 

  2. Braune S, Sieweke A, Brettner F, Staudinger T, Joannidis M, Verbrugge S et al (2016) The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case–control study. Intensive Care Med 42:1437–1444. doi:10.1007/s00134-016-4452-y

    Article  CAS  PubMed  Google Scholar 

  3. Del Sorbo L, Pisani L, Filippini C, Fanelli V, Fasano L, Terragni P et al (2015) Extracorporeal CO2 removal in hypercapnic patients at risk of noninvasive ventilation failure: a matched cohort study with historical control. Crit Care Med 43:120–127

    Article  PubMed  Google Scholar 

  4. Abrams DC, Brenner K, Burkart KM, Agerstrand CL, Thomashow BM, Bacchetta M et al (2013) Pilot study of extracorporeal carbon dioxide removal to facilitate extubation and ambulation in exacerbations of chronic obstructive pulmonary disease. Ann Am Thorac Soc 10:307–314

    Article  CAS  PubMed  Google Scholar 

  5. Sklar MC, Beloncle F, Katsios CM, Brochard L, Friedrich JO (2015) Extracorporeal carbon dioxide removal in patients with chronic obstructive pulmonary disease: a systematic review. Intensive Care Med 41:1752–1762

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stefan Kluge.

Ethics declarations

Conflicts of interest

SB has received lecture honoraria from Novalung GmbH, Heilbronn, Germany. SK is a member of the advisory board of Novalung GmbH and therefore has received advisor honoraria.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Braune, S., Kluge, S. ECCO2R in COPD exacerbation: response to comments by Del Sorbo et al.. Intensive Care Med 42, 1832–1833 (2016). https://doi.org/10.1007/s00134-016-4511-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-016-4511-4

Keywords

Navigation